Browsing publications by Dr David Kavanagh

Newcastle AuthorsTitleYearFull text
Professor Neil Sheerin
Dr David Kavanagh
Professor Tim Goodship
Dr Sally Johnson
A national specialised service in England for atypical haemolytic uraemic syndrome – the first year’s experience2015
Dr Edwin Wong
Dr David Kavanagh
Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome2015
Rachael Watson
Dr Karim Bennaceur
Catriona Barker
Dr David Kavanagh
Professor Tim Goodship
et al.
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)2015
Dr Edwin Wong
Rachel Challis
Professor Neil Sheerin
Dr Sally Johnson
Dr David Kavanagh
et al.
Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS)2015
Dr David Kavanagh
Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels2015
Dr David Kavanagh
Structural basis for sialic acid-mediated self-recognition by complement factor H2015
Dr Vicky Brocklebank
Dr Edwin Wong
Professor Tim Goodship
Dr David Kavanagh
Atypical haemolytic uraemic syndrome associated with a CD46 mutation triggered by Shigella flexneri2014
Catriona Barker
Dr David Kavanagh
Professor Tim Goodship
Dr Kevin Marchbank
Autoantibodies to CD59, CD55, CD46 and CD35 are not associated with aHUS2014
Dr Edwin Wong
Dr Holly Anderson
Rachel Challis
Dr Lisa Turnbull
Daniel Ahlert
et al.
Characterization of a Factor H Mutation That Perturbs the Alternative Pathway of Complement in a Family with Membranoproliferative GN2014
Dr David Kavanagh
Professor Neil Sheerin
Management of hemolytic uremic syndrome2014
12345678